Global MAMMALIAN Market 2016 Research Report DF | Page 2

Report Highlights
DelveInsight’s, “Mammalian target of rapamycin (mTOR) inhibitors -Pipeline
Insights, 2016”, report provides comprehensive insights about pipeline drugs
accross this mechanism of action. Key objective of the report is to establish the
understanding for all the pipeline drugs that fall under Mammalian target of
rapamycin (mTOR) inhibitors. The Report gives insights on 20+ products, 18+
companies that are active in this field and 5 different technologies used in the
pipeline. This report also provides information on the therapeutic development
based on the mTOR inhibitors dealing with all the pipeline drugs, comparative
analysis mTOR inhibitors at various stages covering Filed, Phase III, Phase II, Phase
I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment
by monotherapy and combination products and molecule type drug information.
It covers 5+ therapy areas that are being targeted by mTOR inhibitors. The report
also covers the company’s information involved in the therapeutic development
of the products.

Avail more information from Sample
Brochure of report